Research / BRZE / Fundamental state Inspectable configuration
State dimensions Filing 0001676238-26-000040 General Corporate
Capex intensity 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.51% · OPTIONAL · VALID
Operating cash generation 67th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.66% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
26.16% · CORE · VALID
Gross margin 11th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
66.83% · CORE · VALID
Operating margin 100th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
-7.98% · CORE · VALID
R&D intensity 5th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.92% · OPTIONAL · VALID
SBC intensity 5th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
15.69% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Oct 31, 2021 0/4 normalized Level 3 Jan 31, 2022 0/6 normalized Level 3 Apr 30, 2022 0/6 normalized Level 3 Jul 31, 2022 0/6 normalized Level 3 Oct 31, 2022 0/7 normalized Level 3 Jan 31, 2023 0/7 normalized Level 3 Apr 30, 2023 0/7 normalized Level 3 Jul 31, 2023 0/7 normalized Level 3 Oct 31, 2023 4/7 normalized Level 3 Jan 31, 2024 6/7 normalized Level 3 Apr 30, 2024 6/7 normalized Level 3 Jul 31, 2024 6/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.05%
Current 0.51%
Delta 0.46% Cash Generation Decreased
Previous 13.33%
Current 10.66%
Delta -2.67% Growth Decreased
Previous 30.20%
Current 26.16%
Delta -4.04% Margin Increased
Previous 65.72%
Current 66.83%
Delta 1.11% Profitability Increased
Previous -13.04%
Current -7.98%
Delta 5.06% R And D Intensity Decreased
Previous 21.85%
Current 19.92%
Delta -1.92% Sbc Intensity Decreased
Previous 16.97%
Current 15.69%
Delta -1.28% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Apr 30, 2026
Similarity 91%
Compared 7 dimensions
Coverage 100% Growth 10.0 · Margin 10.5 · Profitability 0.0 · Sbc Intensity 0.3 · Capex Intensity 16.3 · Cash Generation 9.8 · R And D Intensity 5.8 Oct 31, 2025
Similarity 82%
Compared 7 dimensions
Coverage 100% Growth 15.0 · Margin 8.2 · Profitability 12.5 · Sbc Intensity 26.0 · Capex Intensity 4.4 · Cash Generation 6.7 · R And D Intensity 32.2 Apr 30, 2025
Similarity 75%
Compared 7 dimensions
Coverage 100% Growth 40.0 · Margin 32.3 · Profitability 28.6 · Sbc Intensity 9.0 · Capex Intensity 14.5 · Cash Generation 17.9 · R And D Intensity 16.2 Oct 31, 2024
Similarity 68%
Compared 7 dimensions
Coverage 100% Growth 40.0 · Margin 64.5 · Profitability 16.7 · Sbc Intensity 3.1 · Capex Intensity 5.1 · Cash Generation 30.3 · R And D Intensity 3.1 Jan 31, 2024
Similarity 63%
Compared 6 dimensions
Coverage 86% Margin 56.1 · Profitability 22.2 · Sbc Intensity 50.3 · Capex Intensity 15.3 · Cash Generation 8.3 · R And D Intensity 39.2 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.